These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 15756594
1. Expression of ADAM15 in lung carcinomas. Schütz A, Härtig W, Wobus M, Grosche J, Wittekind Ch, Aust G. Virchows Arch; 2005 Apr; 446(4):421-9. PubMed ID: 15756594 [Abstract] [Full Text] [Related]
2. ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. Beck V, Herold H, Benge A, Luber B, Hutzler P, Tschesche H, Kessler H, Schmitt M, Geppert HG, Reuning U. Int J Biochem Cell Biol; 2005 Mar; 37(3):590-603. PubMed ID: 15618016 [Abstract] [Full Text] [Related]
3. ADAM15 to α5β1 integrin switch in colon carcinoma cells: a late event in cancer progression associated with tumor dedifferentiation and poor prognosis. Toquet C, Colson A, Jarry A, Bezieau S, Volteau C, Boisseau P, Merlin D, Laboisse CL, Mosnier JF. Int J Cancer; 2012 Jan 15; 130(2):278-87. PubMed ID: 21190186 [Abstract] [Full Text] [Related]
4. ADAM8 as a novel serological and histochemical marker for lung cancer. Ishikawa N, Daigo Y, Yasui W, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y. Clin Cancer Res; 2004 Dec 15; 10(24):8363-70. PubMed ID: 15623614 [Abstract] [Full Text] [Related]
5. ADAM15 targets MMP9 activity to promote lung cancer cell invasion. Dong DD, Zhou H, Li G. Oncol Rep; 2015 Nov 15; 34(5):2451-60. PubMed ID: 26323669 [Abstract] [Full Text] [Related]
6. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation. Chen Q, Meng LH, Zhu CH, Lin LP, Lu H, Ding J. Int J Biochem Cell Biol; 2008 Nov 15; 40(10):2164-73. PubMed ID: 18387333 [Abstract] [Full Text] [Related]
7. Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling. Böhm BB, Aigner T, Roy B, Brodie TA, Blobel CP, Burkhardt H. Arthritis Rheum; 2005 Apr 15; 52(4):1100-9. PubMed ID: 15818704 [Abstract] [Full Text] [Related]
8. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Matsuda Y, Yamamoto T, Kudo M, Kawahara K, Kawamoto M, Nakajima Y, Koizumi K, Nakazawa N, Ishiwata T, Naito Z. Int J Oncol; 2008 Dec 15; 33(6):1177-85. PubMed ID: 19020750 [Abstract] [Full Text] [Related]
9. ADAM15 upregulation and interaction with multiple binding partners in inflammatory bowel disease. Mosnier JF, Jarry A, Bou-Hanna C, Denis MG, Merlin D, Laboisse CL. Lab Invest; 2006 Oct 15; 86(10):1064-73. PubMed ID: 16894352 [Abstract] [Full Text] [Related]
10. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ, Bunn PA, Franklin W, Magill-Solc C, Hartmann C, Helfrich B, Gilman L, Folkvord J, Helm K, Miller YE. Cancer Res; 1996 Feb 15; 56(4):831-9. PubMed ID: 8631021 [Abstract] [Full Text] [Related]
11. Distinct claudin expression profile in histologic subtypes of lung cancer. Moldvay J, Jäckel M, Páska C, Soltész I, Schaff Z, Kiss A. Lung Cancer; 2007 Aug 15; 57(2):159-67. PubMed ID: 17418912 [Abstract] [Full Text] [Related]
12. Biliary glycoprotein mRNA expression is increased in primary lung cancer, especially in squamous cell carcinoma. Ohwada A, Takahashi H, Nagaoka I, Kira S. Am J Respir Cell Mol Biol; 1994 Aug 15; 11(2):214-20. PubMed ID: 8049082 [Abstract] [Full Text] [Related]
13. Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria. Arndt M, Lendeckel U, Röcken C, Nepple K, Wolke C, Spiess A, Huth C, Ansorge S, Klein HU, Goette A. Circulation; 2002 Feb 12; 105(6):720-5. PubMed ID: 11839628 [Abstract] [Full Text] [Related]
14. ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer. Lorenzatti Hiles G, Bucheit A, Rubin JR, Hayward A, Cates AL, Day KC, El-Sawy L, Kunju LP, Daignault S, Lee CT, Liebert M, Hussain M, Day ML. PLoS One; 2016 Feb 12; 11(3):e0150138. PubMed ID: 26930657 [Abstract] [Full Text] [Related]
15. Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes. Lee HD, Koo BH, Kim YH, Jeon OH, Kim DS. FASEB J; 2012 Jul 12; 26(7):3084-95. PubMed ID: 22505472 [Abstract] [Full Text] [Related]
16. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma. Graff L, Castrop F, Bauer M, Höfler H, Gratzl M. Cancer Res; 2001 Mar 01; 61(5):2138-44. PubMed ID: 11280778 [Abstract] [Full Text] [Related]
17. Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion. Karadag A, Ogbureke KU, Fedarko NS, Fisher LW. J Natl Cancer Inst; 2004 Jun 16; 96(12):956-65. PubMed ID: 15199115 [Abstract] [Full Text] [Related]
18. Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis. Al-Fakhri N, Wilhelm J, Hahn M, Heidt M, Hehrlein FW, Endisch AM, Hupp T, Cherian SM, Bobryshev YV, Lord RS, Katz N. J Cell Biochem; 2003 Jul 01; 89(4):808-23. PubMed ID: 12858346 [Abstract] [Full Text] [Related]
19. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Ito T, Noguchi Y, Satoh S, Hayashi H, Inayama Y, Kitamura H. Mod Pathol; 1998 May 01; 11(5):437-43. PubMed ID: 9619596 [Abstract] [Full Text] [Related]
20. Folate Receptor α Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma. Driver BR, Barrios R, Ge Y, Haque A, Tacha D, Cagle PT. Arch Pathol Lab Med; 2016 Jul 01; 140(7):682-5. PubMed ID: 26599808 [Abstract] [Full Text] [Related] Page: [Next] [New Search]